ACADIA Pharmaceuticals (ACAD)
(Real Time Quote from BATS)
$16.47 USD
+0.16 (0.98%)
Updated Apr 26, 2024 10:10 AM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: AMC |
3/2024 | $0.17 | -71.34% |
Earnings Summary
For their last quarter, ACADIA Pharmaceuticals (ACAD) reported earnings of $0.28 per share, missing the Zacks Consensus Estimate of $0.32 per share. This reflects a negative earnings surprise of 12.50%. Look out for ACAD's next earnings release on May 08, 2024. For the next earning release, we expect the company to report earnings of $0.17 per share, reflecting a year-over-year increase of 162.96%.
Earnings History
Price & Consensus
Zacks News for ACAD
Biotech Stock Roundup: AMLX, ACAD Down on Study Data, MRNA, RGLS Gain on Updates & More
ACAD: What are Zacks experts saying now?
Zacks Private Portfolio Services